Tianjin Zhongxin Pharmaceutical News and Activities

Tianjin Zhongxin Pharmaceutical is one of the...

• CSI 500;
• TOB Iconic 10,000.

Tianjin Zhongxin Pharmaceutical is a company listed under the stock ticker 600329 (CN).

View the org chart displaying its 10 main executives

Most searched biographies at Tianjin Zhongxin Pharmaceutical

• Lei Wang, Chairman of the Board
• Min Guo, Director
• Yoke Pheng Liew, Independent Director

Create your alert
to follow the executive moves at Tianjin Zhongxin Pharmaceutical.

Tianjin Zhongxin Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Corden Pharma has announced the acquisition of AmbioPharm  (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Tianjin Zhongxin Pharmaceutical

Social media about Tianjin Zhongxin Pharmaceutical

• Tianjin Zhongxin Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Tianjin Zhongxin Pharmaceutical on LinkedIn, X (Twitter) & YouTube